Lateral flow assay manufacturing: process, materials, and scale

Lateral flow assay manufacturing is the controlled conversion of membranes, pads, reagents, backing material and plastic housings into a finished test device. In outline, the process runs from material qualification and reagent deposition through drying, lamination, cutting, housing assembly and packaging, with quality control at each stage. Because the assay chemistry is only as reproducible as the physical process that carries it, manufacturing repeatability depends on tight control of dispensing consistency, membrane characteristics, component alignment, humidity and other process parameters. For MedTech R&D engineers moving a lateral flow concept toward commercial production, understanding where complexity accumulates in lateral flow manufacturing is essential for sound decisions on process design, supplier selection and scale-up planning.

This article focuses on production: the components as manufacturing inputs, the process steps for lateral flow test strip manufacturing, the variables that affect repeatability, and the practical considerations for production transfer and scale-up. General assay principles are kept brief here; for a broader explanation of how lateral flow assays work and are made, see What are lateral flow assays and how are they manufactured?

Core components and their manufacturing considerations

A lateral flow assay moves a liquid sample across a series of functional membranes and pads by capillary action. From a manufacturing perspective, each component is a material input with its own specifications, handling requirements and failure modes. The performance of the finished device depends on how consistently these materials are processed and assembled as a system.

The nitrocellulose membrane is the most critical element. It is the reaction zone where test and control lines are deposited, and its pore size, capillary flow time and protein binding capacity strongly influence assay behavior. From a manufacturing standpoint, membrane lot-to-lot variation, sensitivity to humidity and mechanical fragility during handling all need to be managed. Minor variations in membrane lot quality can shift assay performance in ways that are difficult to troubleshoot without robust incoming material and process controls.

The supporting components each add their own manufacturing considerations:

  • Sample pad: Receives the raw sample and conditions it before it reaches the conjugate zone. It is often pre-treated with buffer salts, surfactants or blocking agents, so impregnation and drying consistency affect matrix interference and flow uniformity.
  • Conjugate pad: Holds the dried labeled detection reagent, commonly colloidal gold or latex particles. Conjugate loading volume, drying conditions and pad material all influence release kinetics, which are a major determinant of signal strength and background noise.
  • Absorbent pad: Wicks fluid through the strip and sets the total volume the device can process. Its capacity must be matched to the sample volume and flow rate, and its overlap with the membrane affects flow continuity at that junction.
  • Backing card: Provides mechanical support for the laminated assembly. Adhesive properties, flatness and dimensional stability affect lamination quality and cutting accuracy.
  • Housing, where applicable: Many devices use a plastic cassette that defines the sample port, the result window and the pressure applied to the strip. Housing tolerances and strip-to-housing fit influence flow behavior and visual readout.

Reagent quality and conjugation chemistry add another layer of complexity. Antibody affinity, label stability and the blocking chemistry applied to each surface interact to define limit of detection and shelf life. These parameters should be locked early, because changes to any one of them during scale-up can require revalidation. Assay design and reagent development typically sit with the device developer, who defines the chemistry that the manufacturing process then has to reproduce.

Lateral flow test strip manufacturing process, step by step

The sequence below reflects established industry practice for lateral flow assay production. Specific equipment, formats and parameters vary by product, and the steps a given manufacturing partner performs in-house should always be confirmed for each project.

Material selection and incoming control

Production starts with selecting membranes, pads, backing cards and housing materials that meet the assay’s functional requirements and are available with acceptable lot-to-lot consistency. Incoming materials are checked against specifications before release to production. For nitrocellulose this typically includes capillary flow time, and for pads it may include thickness, absorbency and visual inspection. Material formats, such as sheets or rolls, are chosen with the intended production volume in mind.

Reagent deposition and dispensing

Test and control line reagents are deposited onto the membrane using non-contact dispensing or striping equipment. Line width, position, dispense volume and reagent concentration all need to be held to defined tolerances, because small deviations change signal intensity and reproducibility between strips and between batches. Dispense systems that perform well on small prototype batches do not always maintain the same line uniformity at production speeds, so dispensing performance should be verified at the intended scale rather than assumed.

Conjugate and sample pads are prepared by impregnating or dispensing the relevant reagents onto the pad material at a defined loading volume.

Drying

Drying is a high-impact step. Membranes with deposited reagents and loaded pads are dried under controlled temperature and humidity so that reagents bind and stabilize consistently. Humidity fluctuations during drying can alter conjugate release behavior and line characteristics, which makes environmental control a process requirement rather than a convenience. Residual moisture left in the materials can also affect shelf life.

Lamination

The membrane and pads are laminated onto the backing card in a defined overlapping sequence. The overlap distances between pads and membrane govern fluid transfer at each junction, so accurate placement, consistent pressure and good alignment are critical. Sheet-based or roll-to-roll lamination is selected according to production volume and substrate format.

Cutting

The laminated card is cut into individual strips. Mechanical guillotine or rotary cutting and laser cutting are both used in lateral flow manufacturing. Mechanical cutting is widely used for straight-strip formats; laser cutting can offer greater precision for complex geometries or integration with microfluidic features. Cut quality matters because frayed edges, delamination or inconsistent strip width can affect flow and housing fit.

Housing assembly

Strips are loaded into plastic housings, which define the sample application port, result window geometry and overall device format. Correct strip placement and contact pressure between components are essential for uniform flow. Some products are supplied as strips without a housing, in which case assembly is limited to packaging.

Packaging

Finished strips or cassettes are packaged, most commonly with desiccant in foil pouches to protect against humidity during storage and transport. Nitrogen flushing may be considered for products with particularly moisture- or oxygen-sensitive biochemistry. Packaging integrity directly affects shelf life, which is a key parameter in IVD regulatory documentation.

Manufacturing process overview: variables, defects and quality considerations

The table below summarizes common stages in lateral flow assay production, the variables that most influence them, typical defects and the associated quality considerations. It describes general industry practice and is not a specification for any particular product.

Process stage Key variables Potential defects Quality considerations
Incoming material control Membrane flow time, pad thickness and absorbency, adhesive and backing properties, lot consistency Out-of-specification materials, lot-to-lot performance shifts, damaged or contaminated rolls Defined specifications, certificates of analysis, lot traceability, functional checks on critical materials
Reagent deposition and dispensing Dispense volume, line width and position, reagent concentration, dispensing speed, membrane characteristics Faint, uneven or broken lines, line position drift, bleeding or spreading In-process line inspection, dispense verification, documented parameters and equipment settings
Conjugate and sample pad preparation Loading volume, reagent concentration, pad material, drying profile Uneven conjugate distribution, poor release, high background Controlled preparation records, functional release checks, defined hold times
Drying Temperature, humidity, time, airflow, residual moisture Inconsistent reagent binding, altered release behavior, reduced shelf life Monitored environmental conditions, documented drying parameters, retained monitoring data
Lamination Component overlap, alignment, lamination pressure, adhesive behavior Flow interruption at junctions, misaligned pads, air bubbles, delamination Alignment checks, overlap verification, visual and dimensional inspection
Cutting Strip width, cut method, blade or laser settings, card handling Frayed edges, inconsistent strip width, damaged membrane, delamination at the cut edge Dimensional checks, edge inspection, tooling maintenance records
Housing assembly Strip placement, contact pressure, housing tolerances, assembly method Misplaced strips, flow leakage, restricted or uneven flow, result window misalignment Assembly inspection, fit verification, functional sampling
Packaging Desiccant quantity, seal quality, environmental conditions at pouching, labeling Seal failures, moisture ingress, labeling errors Seal integrity checks, labeling verification, stability data supporting shelf life claims

What affects manufacturing repeatability

Repeatability in lateral flow manufacturing means that devices from different strips, batches and production dates behave consistently. Several factors interact to determine it.

  • Material properties: Variation in membrane flow time, pad absorbency or adhesive behavior changes how fluid moves through the strip. Qualifying materials and tracking lot performance reduces this risk.
  • Dispensing consistency: Line width, position and reagent volume directly affect signal intensity. Dispense stability over long runs matters as much as initial setup.
  • Membrane characteristics: Pore structure, surface chemistry and age influence reagent binding and capillary flow, so process settings tuned on one membrane lot may need confirmation on the next.
  • Alignment and overlap: Pad and membrane overlap, strip position in the housing and cut accuracy all influence fluid transfer between components.
  • Humidity and environment: Humidity during dispensing, drying, lamination and assembly affects reagent behavior and moisture content. Controlled conditions and documented monitoring are standard practice for sensitive steps.
  • Process parameters: Dispense speed, drying profile, lamination pressure and cutting settings should be defined, documented and verified, so that the process does not depend on operator judgment.

Production transfer and scaling from prototype to volume manufacturing

The move from a working prototype to production is where many programs meet their largest challenges. Processes that work reliably at small scale often behave differently on roll-to-roll equipment, automated dispensing systems or high-throughput cutting lines.

Several factors drive this complexity. Dispense systems optimized for small batches may not hold line uniformity at production speeds. Membrane lot variability, manageable at prototype scale, becomes a bigger risk when one production run consumes multiple lots. Environmental controls that are easy to maintain in a laboratory require engineered solutions on a manufacturing floor. Hand-assembled prototypes also hide variability that automated equipment will expose.

Effective lateral flow assay scale-up depends on designing for manufacturability from the start. In practice this means:

  • Selecting materials with known lot-to-lot consistency and secure supply.
  • Specifying process parameters that are achievable on production-scale equipment.
  • Building process controls that can detect drift before it affects product quality.
  • Evaluating cost per device early, since tooling choices, material formats and process sequences that suit a prototype can become uneconomical at volume.
  • Planning batch consistency checks and, where applicable, process validation activities, such as demonstrating that the process reproducibly delivers product meeting its specifications across multiple batches.

Production transfer should be documented, with defined process parameters, acceptance criteria and responsibilities agreed between the device developer and the manufacturing partner. Screentec is a CDMO that supports customer-defined diagnostic and manufacturing projects and treats scalability as a design constraint when selecting manufacturing tools and process formats. Details of its production services are described on the production services page, and its work in the sector is outlined under in vitro diagnostics. The scope of any specific project is defined and confirmed during engagement.

Quality control and regulatory context in LFA manufacturing

Lateral flow assays are generally classified as in vitro diagnostic devices, and their manufacture is subject to the quality and regulatory frameworks of the target market, for example EU IVDR (2017/746) and, in the US, the FDA Quality Management System Regulation, which is aligned with ISO 13485 (previously 21 CFR Part 820). These frameworks expect a documented quality management system with process controls, change management and traceability throughout production. Regulatory responsibility for the finished device remains with the legal manufacturer.

At the manufacturing level, quality control typically focuses on four areas:

  • Incoming material control: Each material lot is checked against defined specifications before use, which for critical materials may include flow rate and functional performance checks.
  • In-process controls: Dispense volume, line position, drying conditions and lamination alignment are monitored during production to catch drift early.
  • Finished device testing: Devices are tested against defined acceptance criteria, which may include visual inspection, functional performance with positive and negative controls and packaging integrity.
  • Environmental monitoring: Humidity-sensitive steps require documented controls, with monitoring data retained as part of the batch record.

ISO 13485 provides the quality management framework within which these controls operate. Working with a contract manufacturer whose quality system covers the relevant processes means that process documentation, batch records and change controls are managed in a way that supports the device manufacturer’s regulatory submissions. Design controls, clinical validation and the design history file remain the responsibility of the device manufacturer. Certification scope and applicability should be confirmed with any prospective partner.

Common manufacturing challenges in lateral flow production

Certain issues recur across lateral flow programs:

  • Lot-to-lot membrane variability that shifts flow time, line intensity or background.
  • Inconsistent line deposition at higher dispensing speeds or over long production runs.
  • Humidity sensitivity during drying and assembly that changes conjugate release or shelf life.
  • Alignment and overlap errors in lamination and housing assembly that disrupt flow.
  • Assay designs not yet suited to production, such as parameters that only work with manual handling or narrow material windows.
  • Late-stage changes to materials, reagents or format that trigger revalidation and delay timelines.

Information to prepare before discussing production with a manufacturing partner

A productive manufacturing discussion depends on clear input from the device developer. Useful information to prepare includes:

  • Product definition: Intended use, device format (strip or cassette), sample type and sample volume.
  • Bill of materials: Membrane, pad and backing materials, housing design and any preferred or fixed suppliers.
  • Reagent information: Reagent types, concentrations, supply arrangements and storage and handling requirements, including who supplies reagents and conjugates.
  • Current process knowledge: Prototype process description, dispensing parameters, drying conditions and known sensitivities, such as humidity or membrane lot effects.
  • Performance and acceptance criteria: Target specifications, test methods and what constitutes a pass or fail.
  • Volume and timeline expectations: Anticipated launch volumes, ramp-up scenarios and cost targets.
  • Regulatory context: Target markets, applicable regulatory pathway and documentation expectations.
  • Responsibility boundaries: Which activities sit with the developer, such as assay chemistry, reagent supply, clinical validation and regulatory submission, and which are proposed for the manufacturing partner.

Choosing a manufacturing partner for lateral flow assay production

Selecting a partner for lateral flow manufacturing requires evaluating both technical capability and process maturity. Not every contract manufacturer has experience with the material handling requirements of lateral flow assays, particularly where microfluidic integration, electrochemical sensing or environmental sensitivity is involved.

Key criteria to evaluate include:

  • Quality system: ISO 13485 certification is a common baseline for IVD contract manufacturing. Confirm that the quality system covers the specific processes relevant to your product.
  • Material conversion capabilities: Roll-to-roll and sheet-based processing, cutting, lamination and precision dispensing are all relevant. Verify which capabilities are in-house and which are subcontracted.
  • Environmental controls: Some production steps require controlled humidity. Ask how conditions are controlled and monitored for your product.
  • Scale-up experience: Look for documented new product introduction processes and an understanding of how tooling and format choices affect unit economics.
  • Scope clarity: Confirm which activities the partner performs for your project, such as manufacturing process development, material qualification and production, and which remain with your team, such as assay chemistry, reagent development and clinical validation. Agreeing this boundary early prevents misaligned expectations and scope creep.

If your team is developing a lateral flow assay or another point-of-care diagnostic device and needs to assess manufacturing feasibility, technical requirements or production transfer, discuss your manufacturing requirements with Screentec to explore how production could be structured for your product and volume targets.

This content was generated with the help of AI and it may contain mistakes

‹ Back to Blog & News